» Authors » Paola Gargiulo

Paola Gargiulo

Explore the profile of Paola Gargiulo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 81
Citations 826
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Marra A, DAssante R, De Luca M, Arcopinto M, Gargiulo P, Valente V, et al.
JACC Heart Fail . 2025 Mar; PMID: 40047762
Background: Growing evidence suggests that reduced activity of the growth hormone (GH)/insulin-like growth factor (IGF)-1 axis is common and associated with poor clinical status and outcome in heart failure (HF)....
2.
Parlati A, Nardi E, Sucato V, Madaudo C, Leo G, Rajah T, et al.
J Cardiovasc Dev Dis . 2025 Feb; 12(2). PMID: 39997498
The growing prevalence in the diagnosis of INOCA (Ischemia with Non-Obstructive Coronary Arteries), ANOCA (Angina with Non-Obstructive Coronary Arteries), and MINOCA (Myocardial Infarction with Non-Obstructive Coronary Arteries) highlights the need...
3.
Parlati A, Nardi E, Marzano F, Madaudo C, Di Santo M, Cotticelli C, et al.
J Clin Med . 2025 Feb; 14(3). PMID: 39941536
Cardiovascular magnetic resonance (CMR) imaging has become a cornerstone in the diagnosis, risk stratification, and management of cardiovascular disease (CVD), particularly heart failure (HF) and cardiomyopathies. Renowned as the gold...
4.
Paolillo S, Basile C, Marzano F, Bruzzese D, Agostoni P, Mattavelli I, et al.
ESC Heart Fail . 2025 Feb; PMID: 39909062
Aims: The last released European guidelines on the management of heart failure (HF) recommend in patients with chronic HF with reduced ejection fraction (HFrEF) a pharmacological approach based on four...
5.
Gargiulo P, Marzano F, Crisci M, Marcucci R, Bruzzese D, Maloberti A, et al.
J Am Coll Cardiol . 2024 Dec; 85(5):536-540. PMID: 39665700
No abstract available.
6.
Fiorillo G, Ghazihosseini S, Agizza S, Lanza F, Piccirillo S, Gargiulo G, et al.
J Med Case Rep . 2024 Nov; 18(1):524. PMID: 39506764
Background: The complications associated with cardiac device implants ranges between 5.3% and 14.3%. Cardiac perforation due to "leads" represent a very rare complication of cardiac device implantation, ranging between 0.3%...
7.
Basile C, Scatteia A, Giacopelli D, Gallo P, Pezzullo S, Mancusi C, et al.
Echocardiography . 2024 Oct; 41(10):e70003. PMID: 39422087
Background: Cardiac resynchronization therapy (CRT) is a standard treatment for patients with heart failure and electrical dyssynchrony. Cardiac magnetic resonance (CMR) is the gold standard for assessing left ventricular (LV)...
8.
Parlati A, Nardi E, Basile C, Paolillo S, Marzano F, Chirico A, et al.
J Public Health Res . 2024 Oct; 13(4):22799036241278817. PMID: 39398345
Cardiovascular diseases (CVD) and mental health disorders (MHD) are respectively the first and second most prevalent diseases in high-income countries and the two most relevant causes of disability worldwide. The...
9.
Madaudo C, Parlati A, Di Lisi D, Carluccio R, Sucato V, Vadala G, et al.
J Cardiovasc Med (Hagerstown) . 2024 Sep; 25(11):766-771. PMID: 39347723
Artificial intelligence has increasingly become an integral part of our daily activities. ChatGPT, a natural language processing technology developed by OpenAI, is widely used in various industries, including healthcare. The...
10.
Nardi E, Santoro C, Prastaro M, Canonico M, Paolillo S, Gargiulo G, et al.
Cardiooncology . 2024 Aug; 10(1):48. PMID: 39113118
Atrial fibrillation (AF) is more common in patients with malignancies than in general population. The pathophysiological processes include the pro-inflammatory condition and the exaggerated inflammatory reaction to chemotherapy, radiotherapy, and...